Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0034-2021

Drug recall · October 21, 2020

Cystaran recall

Why: Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Lots / codes

Lot #: 370655, Exp. 10/31/2020

Quantity
1380 bottles
Company
Leadiant Biosciences, Inc., Gaithersburg, MD
Distribution
PA and Italy
Initiated
September 24, 2020 · Voluntary: Firm initiated
Classified
October 15, 2020
Reported
October 21, 2020
Ended
November 10, 2021
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.